Ethan A. Skerry

Partner, Corporate  

New York 212.430.2670


Ethan Skerry concentrates his practice on mergers and acquisitions, strategic and commercial transactions and corporate counseling for technology, media and life sciences companies, as well as private equity and venture investors.

Ethan advises corporate clients at all stages of growth, from startups to mature public and private companies, in their strategic transactions and liquidity events. He also provides counseling to clients on general corporate matters and has served as outside general counsel to clients in a wide range of industries. In every engagement, Ethan strives to provide his clients with practical and efficient advice that helps them achieve their business objectives.

Ethan has been recognized by numerous publications, including Chambers USA (M&A), The Legal 500 (M&A, Technology Transactions), Super Lawyers (M&A, Securities & Corporate Finance, Corporate Governance & Compliance) and The BTI Consulting Group (Client Service All-Star). Ethan also previously served as an adjunct professor at Seton Hall University Law School, where he taught a course on corporate transactions.

Representative Technology/Media Transactions

  • Billie in its sale to P&G
  • eSilicon in the divestiture of certain assets to Synopsys and sale to Inphi​
  • SignalFX in its $1.05 billion sale to Splunk
  • Peloton in multiple acquisition transactions
  • GF Capital Management in multiple acquisition transactions
  • Segovia in its acquisition by Crown Agents Bank
  • Mphasis in its acquisition of Stelligent Systems
  • Lendup in the restructuring of its credit card business
  • Jama Software in its recapitalization by Insight Venture Partners
  • Mimosa Networks in its acquisition by Airspan Networks
  • Grovo Learning in its acquisition by Cornerstone OnDemand
  • Delphi in its acquisition of nuTonomy
  • Gigya in its acquisition by SAP
  • Bonobos in its acquisition by Walmart
  • The principal investor in the acquisition of Blue Man Group by Cirque du Soleil
  • Bitly in its acquisition by Spectrum Equity
  • Steelwedge in its acquisition by E2Open
  • Zen Planner in its acquisition by Daxko
  • 160/90 in its acquisition by Searchlight Capital
  • Funding Circle in its acquisition of Endurance Lending Networks
  • Behance in its acquisition by Adobe Systems
  • Buddy Media in its $800 million acquisition by, and in Buddy Media’s acquisitions of Spinback and Brighter Option
  • SNL Financial in its leveraged recapitalization by New Mountain Capital

Representative Life Sciences Transactions

  • Mavupharma in its acquisition by Abbvie
  • Propeller Health in its acquisition by ResMed
  • Corium International in its acquisition by Gurnet Point Capital
  • Celenex in its acquisition by Amicus Therapeutics
  • Channel Medsystems in its merger agreement with Boston Scientific​
  • Covis Pharma and Covis Injectables in their all-cash $1.2 billion sale of assets to Concordia Healthcare
  • G&W Laboratories in its acquisition of Teva Pharmaceuticals’ manufacturing plant and portfolio of pharmaceutical products
  • Cerberus Capital Management in its $105 million control investment in PaxVax
  • Caladrius in its acquisition of California Stem Cell
  • Covis Pharma in its acquisitions of pharmaceutical products from Sanofi and Bayer AG
  • Cerberus Capital Management in its investment in Covis Pharma
  • Princeton Pharma Holdings and its wholly owned subsidiary Aton Pharma in their $318 million acquisition by Valeant Pharmaceuticals
  • Celldex Therapeutics in its $93.5 million acquisition of CuraGen, and in its $129 million stock-for-stock merger with Avant Immunotherapeutics
  • Vital Signs in its $870 million cash merger with GE Healthcare
  • LifeCell in its $1.7 billion two-step tender offer/merger with Kinetic Concepts
  • GF Capital Private Equity Fund in its acquisition of the assets of Airborne Health

Representative Other Transactions

  • The Estée Lauder Companies in its $1.4 billion acquisition of Too Faced Cosmetics and its acquisitions of Le Labo and Applied Genetics Incorporated Dermatics
  • Indorama Ventures, in its acquisitions of CEPSA Chimie Montreal, the U.S. and Mexican polyester and PET resins business of Invista and FiberVisions from Snow Phipps Group
  • Cytec Industries in the $105 million acquisition of its pressure-sensitive adhesives business by Henkel